Krystyna Michalak

2PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 09, 2020
Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells.

Olga Wesołowska, Krystyna Michalak, Maria Błaszczyk

|Mar 01, 2019
The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells.

Kamila Środa-Pomianek, Krystyna Michalak, Anna Palko-Łabuz

Pageof 1